Journal
IMMUNOBIOLOGY
Volume 216, Issue 6, Pages 715-724Publisher
ELSEVIER GMBH, URBAN & FISCHER VERLAG
DOI: 10.1016/j.imbio.2010.10.008
Keywords
PGlyRP3; Fatty acids; Inflammation; PPAR; Caco2
Categories
Funding
- GALAB Technologies GmbH, Geesthacht, Germany
- Foerderer und Freunde der BafM, Kiel, Germany
Ask authors/readers for more resources
PGlyRPs recognize bacterial peptidoglycan and function in antibacterial innate immunity. Focusing on the interference between nutrition and recognition pattern proteins, free fatty acids (FFA) of dietary and bacterial sources may exert their immunological response through modulating the expression level of the PGlyRPs in enterocytes. PGlyRP3 was the only PGlyRPs member expressed in Caco2 cells. In silica analysis showed that the promoter of PGlyRP3 has some PPRE regions that, as tested by EMSA, bind physically to the PPAR gamma-RXR alpha complex. PGlyRP3 gene expression was induced by PPAR gamma ligands including GW1929 and some FFA. Overexpression of PGlyRP3 in Caco2 cells down regulated the expression of the inflammatory cytokines IL-8, IL-12 and INF-alpha, while its silencing increased the expression of these cytokines. FFA that induced the PGlyRP3 inhibited the tested cytokines. Silencing of PGlyRP3 gene caused the same FFA to increase the cytokine gene expression. A negative regulation of NF-kappa B pathway, including up-regulation of I kappa beta-alpha and down regulation of NF-kappa B and COX-2, is involved in the anti-inflammatory effects of PGlyRP3. In conclusion, PPAR gamma mediates a modulation of PGlyRP3 gene expression, which is involved in inhibiting inflammation through negative regulation of NF-kappa B pathway. (C) 2010 Elsevier GmbH. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available